Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Syra Health Corp. - Class A Common Stock (NQ: SYRA )

0.4707 -0.0133 (-2.75%)
Streaming Delayed Price Updated: 9:55 AM EST, Feb 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Syra Health Corp. - Class A Common Stock

< Previous 1 2 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is Syra Health Stock Surging Today?
Syra Health sees a surge in stock prices after securing a significant contract with Washington D.C. for student healthcare services. Syra Health will deploy nurses and assistants to support student... 
Via Benzinga
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Preview: Syra Health
Via Benzinga
Why Syra Health Stock Is Down 50% Today
Syra Health shares are trading lower by 53% Thursday morning. The company priced a $2.1 million public offering. 
Via Benzinga
(SYRA) - Analyzing Syra Health's Short Interest
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
SYRA Stock Earnings: Syra Health Misses EPS, Beats Revenue for Q2 2024
SYRA stock results show that Syra Health missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Syra Health Wins Contract Valued At Nearly $6M To Train Indiana Health Workers
Syra Health Wins Contract Valued At Nearly $6M To Train Indiana Health Workers 
Via News Direct
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Syra Health Corp. (NASDAQ: SYRA) Surges Ahead: Q1 2024 Sees 47% Revenue Growth and $3.2 Million Cash Balance
Syra Health Corp. (NASDAQ: SYRA) Surges Ahead: Q1 2024 Sees 47% Revenue Growth and $3.2 Million Cash Balance 
Via News Direct
SYRA Stock Earnings: Syra Health Misses EPS, Beats Revenue for Q1 2024
SYRA stock results show that Syra Health missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
SYRA Stock Earnings: Syra Health Misses EPS, Misses Revenue for Q4 2023
SYRA stock results show that Syra Health missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 25, 2024
Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million. 
Via Benzinga
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
The CMS is reviewing the FDA's action to expand use of Wegovy to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or... 
Via Benzinga
Exposures Product Safety
Syra Health (NASDAQ: SYRA) Wins $650,000 Healthcare Quality Improvement Contract
--News Direct-- 
Via News Direct
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.